The Current Ratio as of December 2024 (TTM) for Enlivex Therapeutics Ltd. (ENLV) is 9.71

According to Enlivex Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 9.71. This represents a change of 17.02% compared to the average of 8.30 of the last 4 quarters.

Enlivex Therapeutics Ltd. (ENLV) Historical Current Ratio (quarterly & annually)

How has ENLV Current Ratio performed in the past?

The mean historical Current Ratio of Enlivex Therapeutics Ltd. over the last ten years is 8.82. The current 9.71 Current Ratio has changed 10.91% with respect to the historical average. Over the past ten years (40 quarters), ENLV's Current Ratio was at its highest in in the June 2021 quarter at 20.29. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Enlivex Therapeutics Ltd. (ENLV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Enlivex Therapeutics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enlivex Therapeutics Ltd. (ENLV) Average Current Ratio

How has ENLV Current Ratio performed in the past?

The current Current Ratio of Enlivex Therapeutics Ltd. (ENLV) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Enlivex Therapeutics Ltd. (ENLV) Current Ratio vs. Peers

How is ENLV’s Current Ratio compared to its peers?

Enlivex Therapeutics Ltd.’s Current Ratio is greater than Pluri Inc. (5.90), greater than BioLineRx Ltd. (1.52), greater than Purple Biotech Ltd. (1.27), greater than Aridis Pharmaceuticals, Inc. (0.24), greater than Histogen Inc. (4.05), less than PMV Pharmaceuticals, Inc. (13.98), greater than Aptevo Therapeutics Inc. (1.70), greater than Protalix BioTherapeutics, Inc. (1.98), greater than Corvus Pharmaceuticals, Inc. (0.92), greater than Phio Pharmaceuticals Corp. (6.38), greater than Rain Therapeutics Inc. (5.58), greater than CollPlant Biotechnologies Ltd. (5.38), less than Keros Therapeutics, Inc. (19.03), greater than Merus N.V. (8.32), greater than Vericel Corporation (4.61), less than Century Therapeutics, Inc. (10.39), greater than Aldeyra Therapeutics, Inc. (6.80), greater than Gamida Cell Ltd. (0.35), greater than Checkpoint Therapeutics, Inc. (0.29),

Build a custom stock screener for Enlivex Therapeutics Ltd. (ENLV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enlivex Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enlivex Therapeutics Ltd. (ENLV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enlivex Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.